InvestorsHub Logo
Followers 22
Posts 1717
Boards Moderated 0
Alias Born 10/22/2013

Re: Pablo3131 post# 28874

Friday, 11/17/2017 8:25:59 AM

Friday, November 17, 2017 8:25:59 AM

Post# of 30990
I would have at least some trepidation about taking a neutraceutical that has not been really "vetted" like this Hydrapharm product. Also, to be frank, the "apparent" lack of interest in anatabine synthesis patent also makes me even wonder about the science backing Anatabine...or maybe it's just the value of the patent itself? I don't mean to overstate this, but I think in reality we need to consider all angles for why our investment in this company has failed.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.